Analytical testing, QC

Concept Life Sciences providing ‘fully integrated offering’ in the early development space

24-Jun-2019 By Melissa Fassbender

The drug discovery, development, and analytical service provider has opened a new facility in Sandwich, UK to support the development and manufacturing of APIs – a market expected to top $270bn by 2026.

FDA to ‘institutionalize’ compounding regulation to ‘protect consumers’

19-Jun-2019 By Nick Taylor

The US FDA is set to center its drug compounding regulatory program in an office focused on stopping poor quality, unsafe and ineffective drugs reaching patients.

Aptar scoops up two pharma services firms in $50m deal

11-Jun-2019 By Melissa Fassbender

Aptar Group acquires two pharmaceutical services companies, Nanopharm and Gateway Analytical, to boost its analytical, testing, and development capabilities.

GSK spinoffs join forces as single CRO providing immunology lab services

10-Jun-2019 By Melissa Fassbender

Neomed-Labs/Pacific Biomarkers last week announced its acquisition of PairImmune in a bid to expand its immunology offerings.

Covance to invest $5.7m in new equipment, hire 203 at Indianapolis site

10-Jun-2019 By Melissa Fassbender

Covance seeks an Economic Revitalization Area designation at its Indianapolis, IN-based site, at which the company looks to expand its sample storage capacity and add space “dedicated to innovation" as part of an $11.8m construction project.

ElevateBio secures $150m to move cell and gene therapy companies forward amid ‘overwhelming’ CMO demand

06-Jun-2019 By Melissa Fassbender

ElevateBio’s BaseCamp facility will provide “bench-to-bedside” services to its portfolio and partner companies – as the demand for cell and gene therapy CMOs “far outweighs the capacity,” says CEO.

Scientist.com teams up with VC firm to create marketplace for biotech

03-Jun-2019 By Melissa Fassbender

The online marketplace for outsourced R&D services Scientist.com partners with 5AM Ventures to help researchers save time and money – as the industry is "caught between a rock and a hard place," says CEO.

Accenture launches AI tool to improve connectivity between researchers

30-May-2019 By Vassia Barba

Accenture’s technology platform, Intient, will provide access to clinical data and links companies working on drug delivery.

BASi acquires Smithers Avanza’s tox services business unit

06-May-2019 By Melissa Fassbender

Bioanalytical Systems acquires Smithers Avanza Toxicology Services business unit in response to a strong demand for its toxicology and drug disposition services.

Lonza serves small biotech with services to accelerate movement to the clinic

06-May-2019 By Maggie Lynch

Lonza announces service offering to accelerate the movement of poorly-soluble small molecules into first-in-human clinical trials.

Charles River extends Huntington’s Disease collaboration, shutters site in San Diego

15-Apr-2019 By Melissa Fassbender

Charles River Laboratories has extended its ongoing collaboration with the CHDI Foundation by five-years – and is closing its San Diego, CA-based research model production facility.

Quantified ‘immune age’ could transform drug development, disease management: CytoReason

08-Apr-2019 By Melissa Fassbender

Researchers describe a technique to quantify a person’s “immune age,” information which could help design and analyze clinical trials – improving the drug development process, among other “impressive” possibilities, says industry expert.

Catalent expands HME capabilities at drug development center of excellence

08-Apr-2019 By Maggie Lynch

Catalent Pharma invests $5m in drug development center of excellence to expand its hot melt extrusion capabilities for formulation and drug delivery method optimization.

Constrained by outsourced testing? Study shows viability of in-house assessment

04-Apr-2019 By Melissa Fassbender

Clinical trials often rely on outsourced testing which poses potential logistical and cost challenges, though researchers recently demonstrated the viability of bringing these tests in-house to speed turnaround time – and more quickly match patients to...

People on the Move: Outsourcing-Pharma roundup March ‘19

29-Mar-2019 By Melissa Fassbender

The industry in March saw new c-suite appointments at CRF Bracket, PCI Pharma Services, George Clinical, and Paragon Bioservices – as well as moves to boost medical device and DMPK services at Premier Research and Sygnature Discovery, respectively.